{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:29:02Z","timestamp":1793374142712,"version":"4.5.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Psoriasis is a chronic immune-mediated inflammatory skin disorder, frequently associated with comorbidities such as obesity, which can exacerbate its severity and hinder treatment efficacy. Psoriasis pathogenesis involves complex interactions among genetic, environmental, hormonal factors, and is characterized by dysregulated immune responses. In this study, we investigated the relationship between obesity and psoriasis, exploring the impact of circulating levels of adipokines on disease severity, comorbidities, and treatment response to anti-IL-17 and anti-IL-23 biologics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted an observational study that included 91 patients with psoriasis eligible for biological therapy, as well as 26 healthy controls. Disease severity was assessed using PASI, along with the measurement of body composition. Serum samples were analyzed for the measurement of adipokine levels and lipid profiles. Clinical parameters, bioelectrical impedance analysis (BIA), serum adipokine levels (leptin, visfatin, adiponectin) and lipid profile were assessed at baseline and after 16 weeks of biologic treatments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Clinical parameters and adiposity-related indices were analyzed in 76 patients at both T0 and 16 weeks of anti-IL-17 and anti-IL-23 biological treatments, while serum adipokine levels were assessed in 66 patients. Psoriatic patients exhibited higher body mass index (BMI), waist circumference, fat mass (FM), and levels of visfatin (a pro-inflammatory adipokine), whereas adiponectin levels (an anti-inflammatory adipokine) were lower compared to controls. Circulating leptin (a pro-inflammatory adipokine) was significantly higher in female psoriatic patients and showed a positive correlation with the PASI score. Leptin also positively correlated with adiposity indices, while adiponectin showed negative correlations. Furthermore, in women, leptin levels were also associated with psoriatic arthritis, hypertension and, at lower extent, with type II diabetes. Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. Notably, higher baseline leptin levels were associated with the failure to achieve an 90% improvement in baseline PASI at W16 of anti-IL-23 biologic treatments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study highlights significant sex-specific differences in the relationships between adipokines, body composition indices, psoriasis severity, comorbidities, and clinical outcome to therapies. Leptin, in particular, may serve as a predictive biomarker for response to anti-IL-23 therapies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1607312","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:39:30Z","timestamp":1752644370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients"],"prefix":"10.3389","volume":"16","author":[{"given":"Roberta","family":"Belli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dattolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sampogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Gubinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Megna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Luordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Scarponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Quaranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Lolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gisondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabatino","family":"Pallotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Albanesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mercurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000010","article-title":"The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis","volume":"8","author":"Guillet","year":"2022","journal-title":"Int J Women\u2019s Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01549","article-title":"The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23681.x","article-title":"Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study","volume":"125","author":"Naldi","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-024-00857-0","article-title":"Managing the patient with psoriasis and metabolic comorbidities","volume":"25","author":"Bellinato","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00117","article-title":"Pathogenesis of chronic plaque psoriasis and its intersection with cardio-metabolic comorbidities","volume":"11","author":"Gisondi","year":"2020","journal-title":"Front Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/1744666X.2016.1213631","article-title":"Co-morbidity in psoriasis: mechanisms and implications for treatment","volume":"13","author":"L\u00f8nnberg","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2008.11","article-title":"Accuracy of body mass index in diagnosing obesity in the adult general population","volume":"32","author":"Romero-Corral","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00640","article-title":"Obesity, fat mass and immune system: role for leptin","volume":"9","author":"Francisco","year":"2018","journal-title":"Front Physiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.09.053","article-title":"National psoriasis foundation. Obesity and psoriasis: from the medical board of the national psoriasis foundation","volume":"63","author":"Bremmer","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1042\/CS20200895","article-title":"The complex role of adipokines in obesity, inflammation, and autoimmunity","volume":"135","author":"Taylor","year":"2021","journal-title":"Clin Sci (Lond)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.593564","article-title":"The important role of leptin in modulating the risk of dermatological diseases","volume":"11","author":"Su","year":"2020","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783X-18-12","article-title":"Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity","volume":"18","author":"Al-Suhaimi","year":"2013","journal-title":"Eur J Med Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1126\/science.1260972","article-title":"Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection","volume":"347","author":"Zhang","year":"2015","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.dci.2016.06.006","article-title":"Leptin as immune mediator: Interaction between neuroendocrine and immune system","volume":"66","author":"Procaccini","year":"2017","journal-title":"Dev Comp Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin, an adipocytokine with proinflammatory and immunomodulating properties","volume":"178","author":"Moschen","year":"2007","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136860","article-title":"Enhanced NAMPT-mediated NAD salvage pathway contributes to psoriasis pathogenesis by amplifying epithelial auto-inflammatory circuits","volume":"22","author":"Mercurio","year":"2021","journal-title":"IJMS"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076390","article-title":"The role of adipokines in the pathogenesis of psoriasis","volume":"24","author":"Kie\u0142bowski","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4062\/biomolther.2020.054","article-title":"The role of leptin in the association between obesity and psoriasis","volume":"29","author":"Hwang","year":"2021","journal-title":"Biomol Ther (Seoul)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03527.x","article-title":"C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy","volume":"24","author":"Coimbra","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22260","article-title":"Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis","volume":"9","author":"Bai","year":"2018","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/life13101947","article-title":"Update on obesity in psoriasis patients","volume":"13","author":"Vata","year":"2023","journal-title":"Life (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1583207","article-title":"The pharmacological management of patients with comorbid psoriasis and obesity","volume":"20","author":"Chiricozzi","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-021-01080-z","article-title":"Impact of body mass index on the efficacy of biological therapies in patients with psoriasis: A real-world study","volume":"41","author":"Pirro","year":"2021","journal-title":"Clin Drug Investig"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/513948","article-title":"Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review","volume":"2010","author":"Fain","year":"2010","journal-title":"Mediators Inflammation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/nu10121971","article-title":"Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome","volume":"10","author":"Barrea","year":"2018","journal-title":"Nutrients"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237598","article-title":"Psoriatic disease and body composition: A systematic review and narrative synthesis","volume":"15","author":"Blake","year":"2020","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094547","article-title":"HDL cholesterol and non-cardiovascular disease: A narrative review","volume":"22","author":"Kjeldsen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-024-01152-w","article-title":"Psoriasis and molecular target therapies: evidence of efficacy in preventing cardiovascular comorbidities","volume":"14","author":"Potestio","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.08.006","article-title":"Comorbidities in psoriasis","volume":"25","author":"Christophers","year":"2007","journal-title":"Clin Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-08-19-5035","article-title":"The multiple comorbidities of psoriasis: The importance of a holistic approach","volume":"49","author":"Daniel","year":"2020","journal-title":"Aust J Gen Pract"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0741","article-title":"Psoriasis and hypertension: a case-control study","volume":"90","author":"Cohen","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jdin.2020.10.012","article-title":"Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis","volume":"2","author":"Graier","year":"2021","journal-title":"JAAD Int"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0243-x","article-title":"The epidemiology of obesity: A big picture","volume":"33","author":"Hruby","year":"2015","journal-title":"Pharmacoeconomics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12030517","article-title":"Analysis of clinical and genetic factors of obesity and psoriasis concomitance-the influence of body mass composition, prevalence of mood disorders, environmental factors and FTO gene polymorphisms (rs9939609, rs1558902)","volume":"12","author":"Czarnecka","year":"2024","journal-title":"Biomedicines"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2018.1419183","article-title":"Effect of anti IL-12\/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients","volume":"18","author":"Galluzzo","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/09546634.2016.1254326","article-title":"Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis","volume":"28","author":"Galluzzo","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16434","article-title":"Obesity as a risk factor for psoriasis","volume":"34","author":"Zachariae","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2021.100025","article-title":"Psoriasis severity, comorbidities, and treatment response differ among geographic regions in the United States","volume":"1","author":"Enos","year":"2021","journal-title":"JID Innov"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103577","article-title":"Global prevalence of obesity in patients with psoriasis: An analysis in the past two decades","volume":"23","author":"Wang","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04619-w","article-title":"Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset \u201csine psoriasis","volume":"38","author":"Caso","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-020-00380-3","article-title":"Deciphering the association between psoriasis and obesity: current evidence and treatment considerations","volume":"9","author":"Paroutoglou","year":"2020","journal-title":"Curr Obes Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/life14060733","article-title":"The intersection of the pathogenic processes underlying psoriasis and the comorbid condition of obesity","volume":"14","author":"Scala","year":"2024","journal-title":"Life (Basel)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20197716","article-title":"Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls","volume":"94","author":"Bavoso","year":"2019","journal-title":"Bras Dermatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048221","article-title":"Measurement of visceral fat and abdominal obesity by single-frequency bioelectrical impedance and CT: a cross-sectional study","volume":"11","author":"Xu","year":"2021","journal-title":"BMJ Open"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06264","article-title":"Correlation of body visceral fat rating with serum lipid profile and fasting blood sugar in obese adults using a noninvasive machine","volume":"7","author":"Sukkriang","year":"2021","journal-title":"Heliyon"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1621979","article-title":"Adiponectin levels in a large pooled plaque psoriasis study population","volume":"31","author":"Gerdes","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-023-01444-9","article-title":"Sex-specific association of visceral and subcutaneous adipose tissue volumes with systemic inflammation and innate immune cells in people living with obesity","volume":"48","author":"Van Den Munckhof","year":"2024","journal-title":"Int J Obes"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2014.11.029","article-title":"The sexual dimorphism of obesity","volume":"402","author":"Palmer","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nm0995-953","article-title":"Increased obese mRNA expression in omental fat cells from massively obese humans","volume":"1","author":"Hamilton","year":"1995","journal-title":"Nat Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.10.4284","article-title":"Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals","volume":"82","author":"Elbers","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1540285","article-title":"Estrogen increases in vivo leptin production in rats and human subjects","volume":"154","author":"Shimizu","year":"1997","journal-title":"J Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.6.913","article-title":"Leptin secretion from subcutaneous and visceral adipose tissue in women","volume":"47","author":"Van Harmelen","year":"1998","journal-title":"Diabetes"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81359-8","article-title":"Adipogenesis and obesity: rounding out the big picture","volume":"87","author":"Spiegelman","year":"1996","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.5625\/lar.2013.29.3.168","article-title":"Effects of estrogen on food intake, serum leptin levels and leptin mRNA expression in adipose tissue of female rats","volume":"29","author":"Fungfuang","year":"2013","journal-title":"Lab Anim Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030690","article-title":"Estrogens in adipose tissue physiology and obesity-related dysfunction","volume":"11","author":"Kury\u0142owicz","year":"2023","journal-title":"Biomedicines"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01474","article-title":"Estrogen metabolism in abdominal subcutaneous and visceral adipose tissue in postmenopausal women","volume":"102","author":"Hetem\u00e4ki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00368","article-title":"Relationships between adipose tissue and psoriasis, with or without arthritis","volume":"5","author":"Toussirot","year":"2014","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2022.2100219","article-title":"Pathogenesis-oriented therapy of psoriasis using biologics","volume":"22","author":"Boehncke","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"B63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40259-022-00569-z","article-title":"Biologic and small-molecule therapies for moderate-to-severe psoriasis: focus on psoriasis comorbidities","volume":"37","author":"Jiang","year":"2023","journal-title":"BioDrugs"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1021\/ja310180c","article-title":"Recycling nicotinamide. The transition-state structure of human nicotinamide phosphoribosyltransferase","volume":"135","author":"Burgos","year":"2013","journal-title":"J Am Chem Soc"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13505","article-title":"Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine","volume":"173","author":"Grolla","year":"2016","journal-title":"Br J Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c160029","article-title":"Regulation and function of extracellular nicotinamide phosphoribosyltransferase\/visfatin","volume":"7","author":"Carbone","year":"2017","journal-title":"Compr Physiol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2018.03.007","article-title":"Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis","volume":"86","author":"Shan","year":"2019","journal-title":"Joint Bone Spine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1607312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:39:32Z","timestamp":1752644372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1607312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2025.1607312"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1607312","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"article-number":"1607312"}}